Harold Snyder
Harold Snyder was an American businessperson who started Biocraft Laboratories, one of the earliest manufacturers of generic drugs.
Early life and education
Snyder was born to a Jewish family in Manhattan and attended Erasmus [Hall High School] in Brooklyn. He attended New York University for his undergraduate studies and was awarded a master's degree from Columbia University in 1950, majoring in natural science.Biocraft Laboratories
He founded Biocraft Laboratories in Fair Lawn, New Jersey, in 1964 together with his wife Beatrice, who headed the company's financial operations and developed its inventory system. The firm produced antibiotics, such as penicillin and tetracycline, waiting for the expiration of patents on brand-name medications and then producing generic equivalents at lower prices. Biocraft was listed on the New York Stock Exchange in 1985, with Snyder stating that it was the first generic drug manufacturer to be listed on the Big Board.The Snyders played a major role in establishing the standards and approval process with the U.S. Food and Drug Administration for generic pharmaceuticals. In 1991, Snyder expressed his concerns regarding FDA approval processes that had multiple chemists raising issues regarding generic versions of brand-name drugs.
The firm was able to produce generic versions in 1981 of Co-trimoxazole, which had been manufactured and sold under the brand names Bactrim and Septra in 1981, with the generics sold for half the price of the brand-name equivalents. Biocraft was able to use documentation previously prepared by Hoffmann–La Roche and Burroughs Wellcome, the original makers of the two drugs, to cut the cost of creating the processes needed to manufacture generic versions and obtain FDA approval. Burroughs Wellcome filed an appeal of the decision to allow approval of the Biocraft generic versions, with Snyder arguing that "Every day they can keep the generics off the market means more money in their pockets".
The firm opened a plant in Missouri in the 1980s that produced the active ingredients for the company's medications, and shipped those products to the Biocraft facilities in New Jersey for assembly and distribution.